Incidence rates of adverse events of special interest: Guillain-Barré syndrome and Bell’s palsy

12/04/2021
02/07/2024
EU PAS number:
EUPAS40527
Study
Finalised
Documents
Study protocol
Study results
Study results
English (372.61 KB - PDF) View document
Study report
Other information
Study, other information
English (167.42 KB - PDF) View document